Gilead Sciences, Inc.’s GILD posted 3% year-over-year growth in total revenues for the third quarter of 2025.Total revenues comprise product sales and royalty, contract and other revenues.While higher ...

A slew of National Institutes of Health grant terminations in the spring left affected Northwestern researchers with few ...

Some lawmakers and advocates are increasingly uncertain whether critical HIV and AIDS services will survive the federal ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

For over three decades, Tulsa CARES — the largest provider of social service programs for low-income individuals living with ...

For those working in global health, and especially on immunisation, it is difficult not to feel despair at the headwinds in ...

More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...

The Global Virus Network (GVN), a coalition of leading medical virologists representing 80+ Centers of Excellence and ...

Compounding issues, many African countries pay four times more interest on their debt than high-income nations despite often ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...